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1. Introduction 
Eukaryotic RNA polymerase B (or II) has often 
been found to exist in two or three forms which differ 
from one another in the molecular weight of their 
largest subunits [l-4] . It has been suggested that the 
form of the enzyme containing the highest molecular 
weight subunit might be the only genetically specified 
enzyme species, serving as a precursor from which 
the other forms are derived by specific proteolysis 
[S] . An alternative suggestion isthat the largest 
subunits of each form of the enzyme are unique gene 
products [l] . 
In extracts of D. melanogaster third instar larvae 
we had previously found only one form of RNA poly- 
merase B, containing as its largest polypeptide a 
species of 174 000 daltons (polypeptide-1) [6]. Using 
specific immunoprecipitation we have now investigated 
the polypeptide composition of D. melanogaster RNA 
polymerase B in extracts from embryos and from a 
line of cultured Drosophila cells. We find that the 
enzyme from embryos also contains the 174 000 
dalton polypeptide-1 ,whereas the enzyme from 
cultured cells contains instead a larger polypeptide of 
approximately 215 000 daltons (polypeptide-0). 
Furthermore, amixing experiment demonstrates that 
embryo extracts contain an activity that degrades poly- 
peptide- to give rise to a polypeptide that migrates in 
a dodecyl sulfate polyacrylamide slab-gel at the posi- 
tion of polypeptide-1. Recently a similar in vitro con- 
version of a 220 000 dalton polypeptide of yeast 
RNA polymerase B was reported [7] ; these findings 
and our results uggest that the different largest poly- 
peptides of RNA polymerase B subclasses are derived 
from a common precursor and are not the products of 
separate genes. 
2. Materials and methods 
The preparation of antibodies directed against 
purified larval RNA polymerase B, the specific 
immunoprecipitation f the enzyme from partially 
fractionated extracts, and the analysis of the antibody 
precipitates by dodecyl sulfate slab-gel electrophoresis 
have been previously described [6]. 
Larvae were grown as before [6] ; embryos were 
collected 12 to 18 h after egg deposition, dechorionat- 
ed in half-strength ‘Clorox’, rinsed thoroughly with 
water, and stored at -7O’C. Cultured cells (Schneider 
line 1 W [ 81) were grown at 25°C in Schneider’s 
Drosophila medium [9] supplemented with 10% fetal 
calf serum (Gibco) either in monolayer culture (T-flasks) 
or in suspension (spinner flasks). 
For radioactive labeling, mid-log phase cells grown 
in suspension were harvested by centrifugation, washed 
3 times with phosphate buffered saline and resuspended 
in Shields and Sang Drosophila medium [lo] lacking 
leucine and fetal calf serum to a final cell density of 
6-8 X lo6 cells/ml. After a 1 h preincubation, [3H] 
leucine (L[4,5-‘Hlleucine, Amersham, 53 Cilmmol) 
was added and labeling performed for 3 h at 25’C. 
The cells were pelleted, washed once, and stored frozen 
in liquid nitrogen. 
RNA polymerase B was partially purified as follows 
(all steps at 0-4OC). Cells or embryos were suspended 
in 2 vol of buffer A [6] containing 0.5% (v/v) 
Nonidet P40 (Fluka). A freshly prepared phenylmethyl- 
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sulfonyl fluoride (PhMeSOsF) solution (10 mg/ml in 
100% ethanol) was added to this and all other buffers 
used in the purification just prior to use to give a final 
PhMeSOsF concentration of 1.72 mM. The suspension 
was homogenized in a Dounce homogenizer (tight 
fitting glass plunger for cells, motor driven Teflon 
plunger for embryos), an equal volume of buffer A/50 
(buffer A containing 50% (v/v) glycerol) containing 
0.60 M ammonium sulfate was added, and the suspen- 
sion was sonicated 8 X 15 s with a MSE sonicator. 
Two volumes of buffer A/25 (buffer A containing 
25% (v/v) glycerol) were added and the solution 
centrifuged 1 h at 120 000 X g. The supernatant was 
poured through 2 layers of Miracloth (Calbiochem) 
and applied over a 4 h period to a 2 ml heparin- 
Sepharose column [ 111 previously equilibrated with 
buffer A/25 containing 0.10 M ammonium sulfate. 
The column was washed with 10 vol of the same 
buffer and then RNA polymerase activities were 
eluted stepwise with 0.60 M ammonium sulfate in 
buffer A/25. The fractions containing peak RNA 
polymerase activity (assayed as described earlier [6] 
except that the specific activity of the tritiated UTP 
was increased 20-fold), about 50% of which was 
inhibited by 2 pg/ml cu-amanitin, were pooled, diluted 
with buffer A/25 to a final ammonium sulfate con- 
centration of 0.09 M, and applied to a 1 ml DEAE- 
cellulose column (Whatman DE-52) previously equili- 
brated with buffer A/25. After washing the column 
with 10 vol of buffer A/25 containing 0.12 M ammo- 
nium sulfate (to elute cw-amanitin-resistant RNA poly- 
merase activity), the RNA polymerase B was eluted 
with 0.30 M ammonium sulfate in buffer A/25; the 
RNA polymerase activity in the 0.3 M salt step was 
entirely of the B type since it was completely inhibited 
by 1 yg/ml a-amanitin. Aliquots of this partially 
purified B enzyme were used for the antibody precipi- 
tation experiments. 
3. Results and discussion 
RNA polymerase B purified from third instar 
larvae of D. melanogaster contains two large subunits 
of 174 000 daltons and 137 000 daltons (polypeptides 1 
and 2), and several small subunits of less than 50 000 
daltons (fig. 1 A); it thus resembles calf thymus RNA 
polymerase form BII [ 1 ] . We found no enzyme in 
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Fig. 1. Polypeptide composition of RNA polymerase B from 
D. mehnoguster larvae, embryos, and cultured cells. Purified 
enzyme or antibody precipitates were solubilized and 
analyzed as described [6] in a dodecyl sulfate slab-gel con- 
taining an acrylamide gradient of 7.5-12% (w/v). (A) RNA 
polymerase B purified from third instar larvae as previously 
described [ 61. (B) Antibody precipitate of purified larval 
enzyme. (C) Antibody precipitate of embryo RNA poly- 
merase B partially purified as described in Materials and 
methods. (D) Antibody precipitate of cultured-cell RNA 
polymerase B partially purified as in Materials and methods. 
H and L indicate heavy and light immunoglobulin chains, 
respectively. 
larvae analogous to calf thymus polymerase BI, 
containing a subunit greater than 200 000 daltons, 
even by antibody precipitation of the larval poly- 
merase at an early stage in the purification and in 
the presence of PhMeSOsF [6]. 
To see if other forms of RNA polymerase B might 
exist at a different growth stage or in a particular cell 
type, we isolated the B enzyme from partially fractionat 
ed extracts of embryos or cultured cells by antibody 
precipitation (Materials and methods), and analyzed 
the composition of the precipitates by dodecyl sulfate 
slab-gel electrophoresis. PhMeSOaF was added to all 
buffers to inhibit any serine-proteases that might be 
present. We found that the embryo enzyme closely 
resembled the larval polymerase in polypeptide com- 
position; in particular its two largest polypeptides 
corresponded to those found in the larval enzyme 
(fig.1 C). In contrast, the RNA polymerase B from the 
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cultured cells differed markedly from the larval 
enzyme; instead of the 174 000 dalton polypeptide-1 , 
it contained as its largest polypeptide a new species 
of approximately 215 000 daltons (polypeptide-0; 
fig. 1 D). Thus the cultured cell enzyme is analogous 
to calf thymus RNA polymerase BI [l] . The antibody 
precipitates from both the embryo and cultured cell 
extracts contained a few low molecular weight poly- 
peptides not found in the purified larval enzyme; 
these remain to be investigated. 
The presence of only RNA polymerase BII in 
extracts of embryos and larvae could indicate that 
form BI is not synthesized at these growth stages, or 
that it is synthesized but then converted to form BII 
by proteolytic alteration of polypeptide-0. To test 
whether embryos contain an activity capable of con- 
verting polypeptide-0 into polypeptide-I we performed 
the following mixing experiment. We prepared a 
[3H]leucine-labeled extract of cultured cells, mixed it 
with an embryo extract, precipitated the RNA poly- 
merase B from the mixed extract with anti-polymerase B 
y-globulins, and analyzed the precipitated polypeptides 
by dodecyl sulfate slab-gel electrophoresis. As a control 
we.performed a similar mixing experiment using 
unlabeled cultured cells instead of embryos. 
Fluorography [ 121 of the slab-gel indicated that 
in the control experiment (radioactive cells mixed 
with unlabeled cells), the radioactive cellular enzyme 
contained polypeptides 0 (approximately 215 000 dal- 
tons) and 2 (137 000 daltons) in approximately equal 
amounts, as expected from the experiment of fig. 1, 
while no species corresponding to polypeptide-1 
(174 000 daltons) was evident (fig.2A). In contrast, 
the radioactive cellular enzyme that had been exposed 
to the embryo extracted contained, relative to poly- 
peptide-2, very little label in polypeptide-0 but 
approximately stoichiometric amounts of label at the 
position of polypeptide-1 (fig.2B). These results 
indicate that embryos contain an activity that, even in 
the presence of PhMeS03F, can proteolytically degrade 
cellular polypeptide-0, to give rise to a polypeptide 
having the same molecular weight as polypeptide-1 .
The proteolytic activity responsible for the degrada- 
tion of Drosophila polypeptide-0 is apparently different 
from that responsible for the degradation of the largest 
polymerase B subunit in yeast [7], since it is not 
inhibited by PhMeS03F. It remains to be determined if 
the proteolysis of RNA polymerase B we observe in 
A B C 
-2 
Fig.2. Polypeptide composition of radioactive cultured-cell 
RNA polymerase B after mixing with non-radioactive cultured 
cells or embryos. Approximately 0.2 g of Schneider 1 W cells, 
labeled with [‘H Jleucine (Materials and methods), were mixed 
either with 1.8 g unlabeled IW cells or with 5 g embryos, and 
RNA polymerase B partially purified and antibody-precipitated 
as described in Materials and methods. The solubilized anti- 
body precipitates were analyzed by dodecyl sulfate slab-gel 
electrophoresis as in tig.1, and the radioactive polypeptides 
were visualized by fluorography [ 121. (A) Radioactive poly- 
peptides precipitated from a portion of the cell-cell extract. 
(B) Radioactive polypeptides precipitated from a portion of 
the cell-embryo extract. (C) Stained gel of purified larval 
RNA polymerase B, for comparison. 
Drosophila extracts occurs only in vitro, or whether 
it might also occur in vivo. 
The fluorographs shown in fig.2 indicate the 
presence in the antibody precipitates of radioactive 
polypeptides that do not correspond to species found 
in the purified larval enzyme. The significance of the 
presence of these polypeptides is not yet known; 
however, the low molecular weight species present in 
the precipitate from the mixing experiment and not 
present in the control experiment might, for example, 
be cleavage products derived from polypeptide-0. 
We have shown that in vitro proteolysis of poly- 
peptide- (215 000 daltons) can lead to formation of 
a species with the same molecular weight as poly- 
peptide-l (174 000 daltons), suggesting that the larger 
species serves as a precursor for the smaller one. This 
would imply that the two polypeptides are products of 
the same gene. Another explanation could be that in 
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vitro proteolysis of polypeptide-0 only fortuitously 
results in the formation of a protein of 174 000 daltons, 
but that this protein is not polypeptide-1; by this 
explanation polypeptides 0 and 1 would be products 
of different genes. Further experiments, uch as a 
comparison of tryptic digests, are required to determine 
whether in fact polypeptide-1 and the 174 000 daltons 
species created in vitro during the mixing experiment 
are identical or not. In the absence of those experi- 
ments, the fact that an apparent conversion of one 
form of RNA polymerase B to another by proteolysis 
has now been observed in organisms as divergent as 
fruit flies and yeast [7], suggests ous that the first 
explanation is more likely and that the two subunits 
are coded by the same gene. Similar conversions might 
explain the multiplicity of B enzymes found in other 
eukaryotes. 
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